Antimetabolites are a type of drug that is an aggressive therapy aimed at helping reduce further joint damage and preserve joint function. The new drug Xatmep is an oral form of methotrexate that can be used to treat polyarticular juvenile idiopathic arthritis in pediatric patients, usually when nonsteroidal anti-inflammatory drugs have been proven to be ineffective.